Oleg E. Akilov

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Youn H. Kim, M. Bagot, Lauren Pinter‐Brown et al. · The Lancet Oncology · 2018 · 645 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

H. Miles Prince, Youn H. Kim, Reinhard Dummer et al. · The Lancet · 2017 · 580 citations

Medicine, Hematology, Oncology +12

Diagnostic Inaccuracy of Smartphone Applications for Melanoma Detection

Joel Wolf, Jacqueline F. Moreau, Oleg E. Akilov et al. · JAMA Dermatology · 2013 · 394 citations · Full text

Medicine, Dermatology, Oncology +17

Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project

Amit Garg, Erica Neuren, Denny Cha et al. · Journal of the American Academy of Dermatology · 2019 · 279 citations · Full text

Education, Health Sciences, Health Assessment +8

The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients

Julia Scarisbrick, Pietro Quaglino, H. Miles Prince et al. · British Journal of Dermatology · 2018 · 236 citations · Full text

Medicine, Oncology, Pathology +16